POTS and Small Fiber Neuropathy: How Dysautonomia and Nerve Damage Overlap

If you're reading this, there's a good chance you already know something is wrong — and that a doctor, a family member, or maybe your own quiet inner voice has told you at some point that it might just be anxiety. Maybe more than once. Maybe for years. I want to say something before we go any further, because I think it matters more than any of the science that comes after: your symptoms are real. The dizziness when you stand. The heart that pounds so hard you can hear it in your ears. The brain fog that swallows the middle of your day. The burning in your feet at night that no one seems to take seriously. These are not in your head. They are in your body, in your nerves, in a small autonomic system that has been quietly misfiring — and there are objective tests that can prove it.

The overlap between POTS — Postural Orthostatic Tachycardia Syndrome — and small fiber neuropathy is one of the most under-recognized stories in modern autonomic medicine. Three to six out of every ten patients with POTS also have measurable small fiber damage on skin biopsy. The two conditions share machinery: the same tiny nerve fibers that carry pain and temperature sensation from your skin also tell the blood vessels in your legs to squeeze when you stand up. When those fibers are damaged, both jobs fail.

This article walks through what POTS actually is, where SFN fits in, how the two get diagnosed, what actually helps, and what to ask your care team. It's long — take it in pieces if you need to.

What POTS Really Is

POTS is a specific, measurable pattern of what happens to your heart when you go from lying down to standing up. The consensus criteria — endorsed by the Heart Rhythm Society, the American Autonomic Society, and Dysautonomia International — are surprisingly precise. Within ten minutes of standing, your heart rate must rise by at least 30 beats per minute (or at least 40 beats per minute if you are between 12 and 19 years old), and your blood pressure must not drop significantly. Those symptoms need to be sustained for at least three months, and they need to be accompanied by the symptoms of orthostatic intolerance — lightheadedness, palpitations, tremulousness, brain fog, exhaustion, and often that awful feeling that gravity itself is fighting you.

The part that trips up almost everyone — including many doctors — is that POTS is not orthostatic hypotension. Orthostatic hypotension means your blood pressure drops when you stand. In POTS, blood pressure holds steady or even rises. The abnormal signal is the heart rate. Your heart is racing because it is compensating for something else going wrong lower in the body. That distinction is what a proper stand test or tilt-table test is designed to catch.

Who gets POTS? Statistically, it's about five women for every one man, and onset is usually somewhere between the teens and the thirties, though it can arrive at any age. Common triggers include viral illnesses (mononucleosis and COVID-19 are the two most talked about right now), pregnancy, surgery, physical trauma, and autoimmune events. Since 2020, the long-COVID wave has pushed POTS into a level of public awareness it never had before — and it's brought with it a similarly sharp rise in small fiber neuropathy diagnoses.

Where Small Fiber Neuropathy Comes In

Small fiber neuropathy — SFN for short — is damage to the very smallest nerve fibers in your peripheral nervous system. These fibers do two big jobs. They carry pain and temperature sensation from your skin to your brain. And they carry autonomic signals in the other direction — telling blood vessels when to constrict, sweat glands when to fire, gut muscles when to contract. Because these fibers are so small and unmyelinated, they don't show up on standard nerve conduction tests. The classical neurology workup usually comes back “normal.” That's part of why so many patients with SFN get told for years that nothing is wrong.

The way SFN is actually diagnosed is with a punch biopsy of skin — usually a 3-millimeter sample from the distal calf, sent to a specialized lab that counts the density of intraepidermal nerve fibers per millimeter of skin (a measure called IENFD, compared against age- and sex-matched norms). If your fiber density is low, you have small fiber neuropathy. It's an objective, reproducible test — nothing fuzzy about it. Our full explainer on small fiber neuropathy covers the diagnostic pathway and the many causes in more depth. POTS-SFN sits inside the broader family of autonomic neuropathy — nerve damage affecting the involuntary systems.

Here is what makes the POTS-SFN overlap so striking: when researchers have systematically skin-biopsied patients who meet POTS criteria, somewhere between 30 and 60 percent of them have reduced fiber density. That's not a small subset — that's a huge fraction of the POTS population walking around with objective, measurable nerve damage that helps explain why their autonomic nervous system isn't doing its job.

The work that opened this door came primarily out of Dr. Christopher Gibbons and Dr. Roy Freeman's lab at Beth Israel Deaconess Medical Center in Boston, starting around 2013. Their skin-biopsy series and follow-ups from Mayo Clinic, Vanderbilt, and other centers have progressively cemented the picture: a substantial slice of POTS is what neurologists now call “neuropathic POTS” — a POTS driven, at least in part, by small fiber damage to the nerves that regulate blood vessel tone.

The Overlap Explained — One Set of Damaged Fibers, Two Sets of Symptoms

Standing up is, from your circulatory system's point of view, a small crisis. Gravity pulls about half a liter of blood down into your legs and abdomen in the first few seconds. Your body has to squeeze the blood vessels in your lower body to push that blood back toward the heart. That baroreflex signal travels through — you guessed it — small autonomic nerve fibers.

When those efferent fibers are damaged, the vessels don't squeeze the way they should. Blood pools in the legs and abdomen. Not enough returns to the heart. Your brain, sensing a threat to its blood supply, floods the system with adrenaline and the heart is asked to beat faster and faster to compensate. That's the tachycardia. It isn't a heart problem — it's a nerve problem expressed through the heart.

Meanwhile, the very same category of fibers, in different bundles, carries pain and temperature signals from your skin, and drives sweat glands and gut motility. Damage produces the SFN symptom cluster — burning feet, pins and needles, patchy numbness, temperature sensitivity, abnormal sweating, heat intolerance, nausea, early satiety, and altered bowel habits. One process, many faces.

The core insight for a POTS-SFN patient: the burning in your feet and the pounding of your heart when you stand aren't two separate problems. They're the same problem showing up in two different systems, because the same fibers do both jobs.

The Four POTS Subtypes (or Phenotypes) — Where Neuropathic Fits

Autonomic specialists describe POTS in terms of subtypes — patterns that hint at the underlying mechanism. Most patients have overlapping features rather than one clean subtype, but the four help explain why different patients respond to different treatments.

Neuropathic POTS. The subtype most closely tied to small fiber neuropathy. Partial denervation of the autonomic nerves supplying lower-body blood vessels means the vessels don't constrict properly on standing. A classic sign is acrocyanosis — the feet turn dusky, purple, or mottled after a few minutes of standing. Skin biopsy is often abnormal.

Hyperadrenergic POTS. A norepinephrine-driven picture — standing plasma norepinephrine above 600 pg/mL, tremulousness, cold and clammy extremities, migraine, and an elevated systolic blood pressure on standing rather than a drop. Anxiety-like symptoms are prominent, which is exactly why these patients are so often misdiagnosed as psychiatric.

Hypovolemic POTS. Low circulating blood volume, low plasma renin activity, and low aldosterone. Often responds strongly to volume expansion — salt, fluids, and sometimes fludrocortisone.

Secondary POTS. POTS driven by another identifiable condition — mast cell activation syndrome, Ehlers-Danlos syndrome (particularly hypermobile type), autoimmune disease, post-viral syndromes (mononucleosis and long-COVID being the two most common right now), or severe deconditioning after prolonged illness.

Most patients don't fit one box. A young woman with post-viral POTS often has features of all three primary subtypes at once, and her treatment plan usually addresses all three. The subtype label matters most when it points toward a specific test (plasma catecholamines for hyperadrenergic) or a specific therapy (fludrocortisone for hypovolemic).

Symptoms Beyond Fast Heart Rate

The tachycardia is the diagnostic marker, but it's rarely the symptom that dominates a patient's daily life. What most patients actually notice — and what most doctors miss for years — is the constellation around it.

Brain fog. A dulling, slowing, difficulty finding words, difficulty holding a train of thought. It's worst when standing or after prolonged upright activity, and it usually improves lying down. It is not depression, not laziness, not a lack of intelligence. It is measurable underperfusion of the brain during orthostatic stress.

Fatigue. Not ordinary tiredness. A bone-deep, disproportionate fatigue that follows even small exertions and often takes days to recover from. This overlaps significantly with the fatigue picture in myalgic encephalomyelitis/chronic fatigue syndrome, and many patients qualify for both diagnoses.

Gastrointestinal symptoms. Nausea, early satiety, bloating, constipation, sometimes diarrhea. In POTS-SFN, this is driven by autonomic dysfunction of the gut, not by an isolated GI disease. Patients often carry an “irritable bowel” or “gastroparesis” diagnosis without anyone connecting it back to the autonomic picture.

Temperature dysregulation. Uncomfortable sensitivity to heat, uncomfortable cold hands and feet, sometimes both in the same day. Hot showers, saunas, hot cars, and heat waves reliably provoke flares.

Exercise intolerance. Patients often describe an ability to exercise that vanishes almost overnight, followed by weeks or months of post-exertional crashes. This isn't deconditioning in the ordinary sense (though secondary deconditioning is a real problem), and pushing through it typically makes things worse. Proper reconditioning has to be graded, recumbent-first, and very patient.

Small fiber symptoms. Burning feet, especially at night. Pins and needles. Patchy numbness. Temperature sensitivity in the extremities. Sometimes itching or electric-shock sensations. Our detailed piece on burning feet syndrome covers this symptom cluster on its own — and it's one of the most reliable clues that POTS may have an SFN component behind it.

Sleep and nighttime symptoms. Racing heart, adrenaline surges at bedtime or on waking, and unrefreshing sleep are common. Symptoms often flare in the small hours as body position, hormone rhythms, and autonomic tone all shift.

Anxiety and mood symptoms. Real, and worth taking seriously — but usually secondary to the physiology, not the cause of it. When the sympathetic nervous system is running unopposed and adrenaline is chronically elevated, you feel anxious because you are physiologically in a fight-or-flight state most of the time. Treating the underlying POTS often reduces the “anxiety” more than any anxiolytic will. Dealing with a chronic condition dismissed for years also leaves genuine psychological work to do — see our piece on neuropathy and mental health.

Getting Diagnosed — Beyond the Stand Test

Getting a proper POTS-SFN diagnosis usually takes a small battery of tests, ideally at a center that sees a lot of dysautonomia. The pieces:

The 10-minute active stand test. Increasingly the preferred first-line test. You lie flat for at least five minutes while a clinician records baseline heart rate and blood pressure. Then you stand up and stay standing for ten minutes while measurements are taken at one-minute intervals. It's simple, physiological, requires no special equipment, and captures the diagnostic pattern in most POTS patients.

The head-up tilt-table test. The historical gold standard. You are strapped to a table that tilts to 60 or 70 degrees and left there for up to ten minutes (sometimes longer, sometimes with pharmacologic provocation). Some patients tilt-positive when they don't stand-positive, and vice versa — the two aren't perfectly equivalent. Tilt is still used, particularly at autonomic specialty centers.

Skin biopsy for IENFD. The definitive test for small fiber neuropathy. A 3-millimeter punch of skin from the distal calf (and sometimes the thigh for a proximal comparison) is sent to a reference lab, where intraepidermal nerve fibers are counted per millimeter and compared to age- and sex-matched norms. A reduced fiber density confirms SFN. This test is available at most academic neurology departments and at a growing number of neuromuscular specialty clinics.

QSART (quantitative sudomotor axon reflex test). Measures sudomotor autonomic function — the ability of small nerve fibers to trigger sweating in response to a small chemical stimulus applied to the skin. Reduced or absent sweat response supports small fiber dysfunction.

Plasma catecholamines, supine and standing. A standing norepinephrine level over 600 pg/mL is one of the pieces that supports the hyperadrenergic subtype.

Rule-out labs. Thyroid studies, morning cortisol, ferritin, B12, celiac serology, autoimmune panels, and — increasingly — mast cell workup (serum tryptase, 24-hour urine metabolites). SFN itself has a long list of potential causes that need to be looked for, and our overview of the neuropathy diagnostic pathway covers those in general.

A note on getting there: this workup is not what most primary care doctors do. If your symptoms fit the picture in this article, ask for a referral to a cardiologist who works with dysautonomia, a neurologist who does autonomic testing, or ideally a center with a dedicated autonomic clinic. Trusted patient organizations — Dysautonomia International in particular — maintain lists of specialists by region.

Non-Drug Management That Actually Helps

The foundation of POTS management is not medication. It's a set of daily habits that, done consistently, can produce dramatic improvement. Most autonomic specialists build the medication plan on top of these — not instead of them.

Salt. The target for most POTS patients is 10 to 12 grams of sodium per day — significantly more than the general population. That usually means intentionally salting food, adding electrolyte packets, and sometimes taking salt tablets. The extra sodium helps the body hold onto water, which expands plasma volume and reduces orthostatic stress.

Fluids. The target is 2 to 3 liters per day of water or electrolyte fluids. Some patients find drinking 16 ounces of cold water fifteen minutes before getting out of bed dramatically reduces the morning severity of symptoms.

Compression. Waist-high compression garments at 30-40 mmHg. Below-the-knee compression alone is usually not enough for POTS, because the pooling is happening in the abdomen and upper thighs, not just the calves. Waist-high compression is what the physiology asks for, though it takes some getting used to. Our full guide to compression garments in neuropathy covers the sizing and fit questions in more detail — compression is one of the highest-yield tools in POTS management.

Reconditioning. This is the single most powerful long-term intervention, and the hardest one to do right. The classic protocol is the Levine or Dallas POTS Protocol — a graded three-month program that begins with recumbent exercise (rowing machine or recumbent bike) and slowly progresses toward upright activity over weeks and months. The CHOP protocol is a pediatric adaptation. What both protocols share is patience — pushing too hard, too fast, triggers post-exertional crashes and sets the whole process back. Working with a physical therapist who understands POTS is worth every dollar it costs.

Heat avoidance. Hot showers, saunas, hot cars, hot beaches, and summer heat waves reliably worsen POTS symptoms. Cool showers, cooling vests, air conditioning, and cold drinks all help. This isn't a preference — heat causes vasodilation, which worsens pooling.

Small, frequent meals. Large meals — particularly large carbohydrate-heavy meals — shunt a lot of blood to the gut, worsening postprandial pooling and often producing a symptomatic crash within thirty minutes to an hour after eating. Smaller meals more frequently distribute that load.

Head-of-bed elevation. Raising the head of your bed by 4 to 6 inches (using bed risers, not just more pillows) modulates the overnight renin-aldosterone response and reduces the morning symptom severity for many patients.

Balance and safety. If you have SFN with reduced foot sensation plus orthostatic symptoms from POTS, your fall risk is real. Grab bars in the shower, a shower chair, avoiding sudden position changes, and keeping a hand on the wall for the first minute after standing are simple protective habits worth building in.

Medications Your Cardiologist or Neurologist May Consider

Medication decisions in POTS belong firmly with a physician who understands the syndrome. What follows is not a menu — it's a map of the territory, so you know what you might hear discussed and what questions to ask.

Fludrocortisone. A synthetic mineralocorticoid that helps the kidney hold onto sodium and water, expanding plasma volume. Most useful in hypovolemic and mixed subtypes. Requires monitoring of potassium and blood pressure.

Midodrine. A peripheral alpha-1 agonist that constricts blood vessels in the lower body, directly countering the pooling problem. Taken three times a day during upright hours. It should not be taken within four hours of lying down, because the vasoconstriction can produce supine hypertension.

Ivabradine. A drug that slows the sinus node's intrinsic firing rate, giving heart rate control without dropping blood pressure. Increasingly used as first-line rate control in POTS, particularly in the hyperadrenergic subtype, because it doesn't produce the fatigue and orthostatic worsening that beta blockers sometimes do.

Low-dose propranolol. A beta blocker used at low doses (10-20 mg) for heart rate control. Can lower blood pressure, so titrated carefully. Some patients do wonderfully on it; others feel worse.

Pyridostigmine. An acetylcholinesterase inhibitor originally developed for myasthenia gravis, used off-label in POTS to enhance autonomic ganglionic transmission. GI side effects (nausea, diarrhea) are the usual limiter.

For the SFN pain component. When burning feet, patchy pain, or electric sensations are prominent, the medications used are the same ones used for other small fiber neuropathies — duloxetine and gabapentin being the most common. Each has its own side-effect profile, and each patient responds differently.

Stimulants. Some clinicians use low-dose methylphenidate off-label for brain fog and mild BP support. This is controversial and appropriately reserved for specialists who know the trade-offs.

The Autoimmune Question

A meaningful subset of POTS-SFN cases appear to be autoimmune in origin. Autoantibodies against G-protein-coupled receptors — the adrenergic α1 and β1/β2 receptors, the muscarinic M2 and M3 receptors — have been found in POTS patients at rates higher than in healthy controls. The ganglionic acetylcholine receptor antibody, associated with autoimmune autonomic ganglionopathy, is occasionally positive. Post-viral triggers (mononucleosis, COVID) are consistent with an autoimmune mimicry mechanism.

For refractory cases with a clear autoimmune signature, intravenous immunoglobulin (IVIG) has been tried at academic centers with cautiously encouraging results. This is investigational — it is expensive, it requires very careful patient selection, and it should only be considered at a specialty center with experience in autoimmune dysautonomia. It is not a first-line therapy, and it is not appropriate for most POTS patients. Vanderbilt, Mayo, Cleveland Clinic, and Johns Hopkins are among the centers doing serious work in this area.

Living Well With POTS-SFN

The medical picture is one piece of it. The living-with-it piece is the other, and it's the piece nobody in a clinic really teaches you.

Pacing. Learn your daily energy envelope and respect it. Big overactive days pay in crashes tomorrow. Steady moderate days accumulate into real function. Many patients find heart-rate monitoring — a simple smartwatch is enough — a useful tool for staying inside their envelope in real time.

Cooling. A cooling vest for hot days, a cool cloth on the neck, cold water bottles. This is not overreaction; it is prevention.

Community and mental health support. Dysautonomia International, Standing Up to POTS, and other patient organizations run online communities where the shared experience of being told you're fine for years meets immediate understanding. A therapist experienced in chronic illness can help you separate physiologically-driven anxiety from the psychological work of grieving the body you thought you'd have.

Advocate for yourself, patiently. If a doctor doesn't take you seriously, find another one. Bring a written symptom list, your heart rate and blood pressure records, and family members if that helps. Ask direct questions and expect direct answers.

Frequently Asked Questions

How is POTS different from just being anxious?

POTS is diagnosed by an objective, measurable rise in heart rate on standing — at least 30 beats per minute in adults, or 40 in adolescents, within ten minutes of standing up, with blood pressure not dropping significantly. Anxiety does not produce that pattern reliably or reproducibly. Many POTS patients are told for years that their symptoms are anxiety before someone actually performs a stand test or tilt-table test. If yours haven't been done, ask for them. The distinction between the two is not subjective; it's a number on a machine.

Can POTS and small fiber neuropathy be reversed?

Improvement is common; complete reversal depends on the underlying cause. Post-viral cases (including many long-COVID cases) often improve substantially over one to three years, and some resolve entirely. Cases tied to a specific reversible trigger (such as an autoimmune process that responds to treatment, or a vitamin deficiency) can improve as the underlying issue is addressed. Cases without a clear reversible cause usually improve substantially with non-drug management and appropriate medication, even if the underlying nerve damage persists. The trajectory is very individual and requires close follow-up with a knowledgeable clinician.

Do I have to do the tilt-table test if a stand test is easier?

Not necessarily. An active stand test performed correctly for a full ten minutes with proper monitoring is diagnostic in most POTS patients. The tilt-table is more sensitive in certain cases and remains the historical gold standard, particularly at autonomic specialty centers. Whether you need one depends on your particular clinical picture and your clinician's judgment.

Should I try IVIG for my POTS-SFN?

Only in the specific context of a strong autoimmune signature, at a specialty center with experience in autoimmune dysautonomia. IVIG is investigational for POTS, is expensive, and is not appropriate for most patients. This is not a first-line therapy and is not something to pursue without a formal workup by an autonomic neurologist.

Can I still exercise if I have POTS-SFN?

Yes, and you should — but the exercise has to be structured correctly. Standard “just push through it” advice will make you worse. The Levine (Dallas) and CHOP protocols are the two most established approaches. They start with recumbent exercise (rowing machine, recumbent bike, swimming) and progress very gradually toward upright work over months. A physical therapist experienced with POTS is worth pursuing. Pacing and heart rate monitoring during exercise help you stay inside your envelope.

Are salt tablets safe to take on my own?

Salt loading is a standard non-drug POTS therapy, but it needs to be cleared with a clinician first — and it is not safe for people with heart failure, chronic kidney disease, uncontrolled hypertension, or certain other conditions. Blood pressure and kidney function should be monitored, particularly if fludrocortisone is added on top of the salt.

Is POTS connected to long COVID?

Yes, strongly. A meaningful percentage of long-COVID patients meet POTS criteria, and skin biopsies in long-COVID patients have found small fiber neuropathy at rates similar to what's seen in classic POTS. The mechanism appears to involve some combination of direct viral effect, autoimmune mimicry, and persistent inflammation. This has been one of the biggest drivers of new POTS diagnoses since 2020.

Where This Leaves You

If most of this article felt like a description of your own life, take that seriously. Objective tests exist. Subtypes and mechanisms give doctors real handles to work with. Non-drug tools produce meaningful improvement in most patients. Medications, chosen carefully, build on top of those tools. And an entire community of patients, clinicians, and researchers now understands this syndrome in a way they did not even ten years ago.

The story you have been told about your symptoms — that they are anxiety, that they are stress, that they are just how you are — is not the last word. Keep asking, keep advocating, and keep looking until you find the person who takes you seriously and orders the workup you deserve.

Take care of yourself. Bring this article to your next appointment if it helps. And when someone tells you your symptoms are all in your head, you can tell them, gently but without apology, that your nerves would like to disagree.

About the Author

View All Posts